Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-13 4:01 pm Purchase |
2024-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 2,350,000 7.290% |
1,100,000![]() (+88.00%) |
Filing History |
2025-02-07 1:21 pm Purchase |
2024-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Invesco Ltd. IVZ |
1,775,760 5.500% |
1,775,760![]() (New Position) |
Filing History |
2024-11-13 5:13 pm Purchase |
2024-09-30 | 13G | Collegium Pharmaceutical, Inc. COLL |
PRINCIPAL GLOBAL INVESTORS | 1,745,663 5.420% |
1,745,663![]() (New Position) |
Filing History |
2024-11-13 4:30 pm Sale |
2024-09-30 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 1,250,000 3.880% |
-1,508,253![]() (-54.68%) |
Filing History |
2024-11-13 2:39 pm Purchase |
2024-08-02 | 13G | Collegium Pharmaceutical, Inc. COLL |
Renaissance Technologies LLC | 1,656,069 5.140% |
1,656,069![]() (New Position) |
Filing History |
2024-02-14 12:04 pm Purchase |
2023-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Eventide Asset Management, LLC | 2,630,478 8.070% |
885![]() (+0.03%) |
Filing History |
2024-02-13 5:02 pm Purchase |
2023-12-29 | 13G | Collegium Pharmaceutical, Inc. COLL |
The Vanguard Group | 2,312,786 7.090% |
104,675![]() (+4.74%) |
Filing History |
2024-02-12 06:06 am Sale |
2023-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 2,758,253 8.460% |
-575,375![]() (-17.26%) |
Filing History |
2024-01-19 2:40 pm Purchase |
2023-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
BLACKROCK INC BLK |
5,786,527 17.700% |
55,222![]() (+0.96%) |
Filing History |
2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 3,333,628 9.930% |
727,128![]() (+27.90%) |
Filing History |
2023-02-09 11:16 am Sale |
2022-12-30 | 13G | Collegium Pharmaceutical, Inc. COLL |
The Vanguard Group | 2,208,111 6.580% |
-79,306![]() (-3.47%) |
Filing History |
2023-02-09 10:36 am Sale |
2022-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
JANUS HENDERSON GROUP PLC JHG |
1,481,170 4.400% |
-506,325![]() (-25.48%) |
Filing History |
2023-01-30 09:55 am Purchase |
2022-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
BLACKROCK INC BLK |
5,731,305 17.100% |
99,645![]() (+1.77%) |
Filing History |
2022-09-12 08:25 am Sale |
2022-08-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
JANUS HENDERSON GROUP PLC JHG |
1,987,495 5.800% |
-1,786,808![]() (-47.34%) |
Filing History |
2022-02-14 9:01 pm Sale |
2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-2,058,068![]() (Position Closed) |
Filing History |
2022-02-14 12:04 pm Purchase |
2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Eventide Asset Management, LLC | 2,629,593 7.600% |
201,617![]() (+8.30%) |
Filing History |
2022-02-14 09:40 am Sale |
2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Camber Capital Management LP | 1,050,000 3.040% |
-950,000![]() (-47.50%) |
Filing History |
2022-02-14 08:41 am Purchase |
2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 2,606,500 7.540% |
680,217![]() (+35.31%) |
Filing History |
2022-02-10 3:21 pm Sale |
2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
JANUS HENDERSON GROUP PLC JHG |
3,774,303 10.900% |
-1,313,206![]() (-25.81%) |
Filing History |
2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
The Vanguard Group | 2,287,417 6.620% |
556,565![]() (+32.16%) |
Filing History |